Northwestern Medicine, Chicago
Northwestern Memorial Hospital, Diagnostic Testing Center (Phlebotomy/EKG), Chicago
Northwestern Memorial Hospital, Investigational Drug Service, Chicago
и још 2

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07919678

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Great Lakes Clinical Trials - Ravenswood, Chicago

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Cedar Crosse Research Center, Chicago
Northwestern University, Chicago
Endeavor Health - Family Medicine Administration, Evanston
и још 1

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

NorthShore University Health System, Skokie

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Great Lakes Clinical Trials - Ravenswood, Chicago

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Great Lakes Clinical Trials - Ravenswood, Chicago

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07353931

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Rush University Medical Center, Chicago

Тражи се учесникФаза 3

Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Rush University Medical Center, Chicago

Тражи се учесникФаза 3

Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937086

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Ann and Robert Lurie Children's Hospital of Chicago, Chicago
University of Illinois at Chicago, Chicago

Тражи се учесникФаза 3

Узраст од 6 до 17 · Оба пола · Ажурирано 4. 11. 2026. · NCT06672549

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Champaign
Research Site, Chicago

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Chicago
Research Site, Melrose Park
Research Site, Oak Brook

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07752979

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Christie Clinic, Champaign

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT07837973

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Great Lakes Clinical Trials - Ravenswood, Chicago

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07589608

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Great Lakes Clinical Trials - Ravenswood, Chicago

Тражи се учесникФаза 2

Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT06143956

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Chicago Research Center, Inc, Chicago

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT07571109

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Flourish Research - Great Lakes Clinical Trials, Chicago
Endeavor Health, Skokie
Evanston Premier Healthcare Research LLC, Skokie

Тражи се учесникФаза 3

Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684235

A Trial to Examine the Effects of a Weight Loss Program Emphasizing Protein, Dietary Fiber, and Exercise (30-30-30 Plan)

Biofortis Clinical Research, Addison
Illinois Institute of Technology, Chicago

Тражи се учесникЗдраве особе су добродошле

Узраст од 18 до 69 · Оба пола · Ажурирано 5. 10. 2026. · NCT07789769

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Endeavor Health, Skokie

Тражи се учесникФаза 3

Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684144

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Great Lakes Clinical Trials, Chicago
Clinical Investigation Spec Gurnee, Gurnee
Endeavor Health, Skokie
и још 1

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Chicago Research Center, Inc, Chicago
Endeavor Health, Skokie

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07668414

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Schaumburg

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Schaumburg

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743463

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

University Of Chicago, Chicago

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 11. 9. 2026. · NCT07571005

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Walgreens - Store 11760, Oak Park

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 4. 9. 2026. · NCT07745504

BRIDGE & Friends Trial

University of Illinois Chicago, Chicago

Тражи се учесникЗдраве особе су добродошле

Узраст од 50 до 79 · Оба пола · Ажурирано 1. 9. 2026. · NCT07798557

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Illinois Institute of Technology, Chicago

Тражи се учесникЗдраве особе су добродошле

Узраст од 21 до 74 · Оба пола · Ажурирано 27. 8. 2026. · NCT07566325

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Clinical Investigation Spec Gurnee, Gurnee
Evanston Premier Hlthcr Res, Skokie

Тражи се учесникФаза 3

Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT07509307

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Chicago

Тражи се учесникФаза 3

Узраст од 18 до 79 · Оба пола · Ажурирано 10. 8. 2026. · NCT07654361

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Jesse Brown VA Medical Center, Chicago

Тражи се учесник

Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT06390345

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

Mile Square Health Center Chicago, Chicago
Mile Square Health Center - Auburn Gresham, Chicago
Mile Square Health Center - Englewood, Chicago
и још 1

Тражи се учесникФаза 2

Сви узрасти · Оба пола · Ажурирано 10. 7. 2026. · NCT07332741

Better Lifestyle Counseling for African American Women During Pregnancy

University of Illinois at Chicago, Chicago
University of Illinois at Chicago, Chicago

Тражи се учесник

Узраст од 18 до 40 · Жене · Ажурирано 9. 7. 2026. · NCT05234125

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Northwestern Memorial Hospital, Chicago

Тражи се учесникОпсервациона студија

Узраст од 18 до 70 · Оба пола · Ажурирано 17. 3. 2026. · NCT07207148

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

University of Chicago, Chicago

Тражи се учесникФаза 3

Узраст од 18 до 75 · Оба пола · Ажурирано 14. 11. 2025. · NCT06499857

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.